Modification of the kinetic stability of immunoglobulin G by solvent additives

No abstract is available for this paper.

• Publication year

  2018

• Venue

  mAbs

• Publication date

  2018-05-19

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1080/19420862.2018.1450126PMID 29537925PMCID PMC5973700
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The fluorescence intensities ratio is not a reliable parameter for evaluation of protein unfolding transitions

  2017cited by this paper
• Analysis of IgG kinetic stability by differential scanning calorimetry, probe fluorescence and light scattering

  2017cited by this paper
• Physicochemical and biological characterization of SB2, a biosimilar of Remicade® (infliximab)

  2016cited by this paper
• A comparison of biophysical characterization techniques in predicting monoclonal antibody stability

  2016cited by this paper
• Orthogonal Methods for Characterizing the Unfolding of Therapeutic Monoclonal Antibodies: Differential Scanning Calorimetry, Isothermal Chemical Denaturation, and Intrinsic Fluorescence with Concomitant Static Light Scattering.

  2016cited by this paper
• Evaluation of the structural, physicochemical, and biological characteristics of SB4, a biosimilar of etanercept

  2016cited by this paper
• Advanced analyses of kinetic stabilities of iggs modified by mutations and glycosylation

  2015influential reference
• Examination of thermal unfolding and aggregation profiles of a series of developable therapeutic monoclonal antibodies.

  2015cited by this paper
• Correlations between changes in conformational dynamics and physical stability in a mutant IgG1 mAb engineered for extended serum half-life

  2015cited by this paper
• Stability engineering of the human antibody repertoire

  2014cited by this paper
• Influence of glycosylation pattern on the molecular properties of monoclonal antibodies

  2014cited by this paper
• A general approach to antibody thermostabilization

  2014cited by this paper
• Aggregation of anti-streptavidin immunoglobulin gamma-1 involves Fab unfolding and competing growth pathways mediated by pH and salt concentration.

  2013cited by this paper
• Perturbation of thermal unfolding and aggregation of human IgG1 Fc fragment by Hofmeister anions.

  2013cited by this paper
• Interactions between l‐arginine/l‐arginine derivatives and lysozyme and implications to their inhibition effects on protein aggregation

  2013cited by this paper
• A critical evaluation of microcalorimetry as a predictive tool for long term stability of liquid protein formulations: granulocyte colony stimulating factor (GCSF).

  2013cited by this paper
• Understanding the relevance of local conformational stability and dynamics to the aggregation propensity of an IgG1 and IgG2 monoclonal antibodies

  2013cited by this paper
• Immunogenicity of therapeutic proteins: Influence of aggregation

  2013cited by this paper
• Effects of salts from the Hofmeister series on the conformational stability, aggregation propensity, and local flexibility of an IgG1 monoclonal antibody.

  2013influential reference
• Characterization of therapeutic antibodies and related products.

  2013cited by this paper
• Thermodynamic and Fluorescence Analyses to Determine Mechanisms of IgG1 Stabilization and Destabilization by Arginine

  2013cited by this paper
• Engineering a therapeutic IgG molecule to address cysteinylation, aggregation and enhance thermal stability and expression

  2013cited by this paper
• General strategy for the generation of human antibody variable domains with increased aggregation resistance

  2012cited by this paper
• Native-state solubility and transfer free energy as predictive tools for selecting excipients to include in protein formulation development studies.

  2012cited by this paper
• Advancements in high throughput biophysical technologies: applications for characterization and screening during early formulation development of monoclonal antibodies.

  2012cited by this paper
• Liquid Formulations for Stabilizing IgMs During Physical Stress and Long-Term Storage

  2012cited by this paper
• Engineering aggregation resistance in IgG by two independent mechanisms: lessons from comparison of Pichia pastoris and mammalian cell expression.

  2012cited by this paper
• Disulfide linkage engineering for improving biophysical properties of human VH domains.

  2012cited by this paper
• Transfer of engineered biophysical properties between different antibody formats and expression systems.

  2012cited by this paper
• Aggregation-resistant domain antibodies engineered with charged mutations near the edges of the complementarity-determining regions.

  2012cited by this paper
• On the role of salt type and concentration on the stability behavior of a monoclonal antibody solution.

  2012cited by this paper
• Excipients differentially influence the conformational stability and pretransition dynamics of two IgG1 monoclonal antibodies.

  2012cited by this paper
• Investigation of protein conformational stability employing a multimodal spectrometer.

  2011cited by this paper
• Protein-excipient interactions: mechanisms and biophysical characterization applied to protein formulation development.

  2011cited by this paper
• Elucidation of Acid-induced Unfolding and Aggregation of Human Immunoglobulin IgG1 and IgG2 Fc

  2011cited by this paper
• Aggregation, stability, and formulation of human antibody therapeutics.

  2011cited by this paper
• Multidimensional methods for the formulation of biopharmaceuticals and vaccines.

  2011cited by this paper
• Evaluation of a non-Arrhenius model for therapeutic monoclonal antibody aggregation.

  2011cited by this paper
• High throughput formulation screening for global aggregation behaviors of three monoclonal antibodies.

  2011cited by this paper
• Structure-based design of conformation- and sequence-specific antibodies against amyloid β

  2011cited by this paper
• Osmolyte effects on protein stability and solubility: a balancing act between backbone and side-chains.

  2011cited by this paper
• Mutational analysis of domain antibodies reveals aggregation hotspots within and near the complementarity determining regions

  2011cited by this paper
• Predicting accelerated aggregation rates for monoclonal antibody formulations, and challenges for low-temperature predictions.

  2011cited by this paper
• Nonnative aggregation of an IgG1 antibody in acidic conditions: part 1. Unfolding, colloidal interactions, and formation of high-molecular-weight aggregates.

  2011cited by this paper
• Chemistry of Hofmeister anions and osmolytes.

  2010cited by this paper
• Strategies and challenges for the next generation of therapeutic antibodies

  2010cited by this paper
• High throughput thermostability screening of monoclonal antibody formulations.

  2010cited by this paper
• Recent trends in stabilising peptides and proteins in pharmaceutical formulation – considerations in the choice of excipients

  2009cited by this paper
• Factors influencing antibody stability at solid–liquid interfaces in a high shear environment

  2009cited by this paper
• Effect of Ions on Agitation- and Temperature-Induced Aggregation Reactions of Antibodies

  2009cited by this paper
• Suppression of protein aggregation by L-arginine.

  2009cited by this paper
• Protein stabilization and the Hofmeister effect: the role of hydrophobic solvation.

  2009cited by this paper
• Effect of Hofmeister ions on protein thermal stability: roles of ion hydration and peptide groups?

  2008cited by this paper
• Comprehensive Analysis of the Factors Contributing to the Stability and Solubility of Autonomous Human VH Domains*

  2008cited by this paper
• Intrabody construction and expression III: Engineering hyperstable VH domains

  2008cited by this paper
• Salts enhance both protein stability and amyloid formation of an immunoglobulin light chain.

  2008cited by this paper
• Contribution of variable domains to the stability of humanized IgG1 monoclonal antibodies.

  2008cited by this paper
• A rapid, sensitive and economical assessment of monoclonal antibody conformational stability by intrinsic tryptophan fluorescence spectroscopy

  2008cited by this paper
• High throughput screening of protein formulation stability: practical considerations.

  2007cited by this paper
• Stability of biocatalysts.

  2007cited by this paper
• Antibody structure, instability, and formulation.

  2007cited by this paper
• Suppression of protein interactions by arginine: a proposed mechanism of the arginine effects.

  2007cited by this paper
• A broad range of Fab stabilities within a host of therapeutic IgGs.

  2007cited by this paper
• Protein Structural Conformation and Not Second Virial Coefficient Relates to Long-Term Irreversible Aggregation of a Monoclonal Antibody and Ovalbumin in Solution

  2006cited by this paper
• Aggregation-resistant domain antibodies selected on phage by heat denaturation

  2004cited by this paper
• Irreversible aggregation of recombinant bovine granulocyte-colony stimulating factor (bG-CSF) and implications for predicting protein shelf life.

  2003cited by this paper
• Why Is Trehalose an Exceptional Protein Stabilizer?

  2003cited by this paper
• Biophysical properties of human antibody variable domains.

  2003cited by this paper
• Protein-solvent preferential interactions, protein hydration, and the modulation of biochemical reactions by solvent components

  2002cited by this paper
• Excipient-drug interactions in parenteral formulations.

  2002cited by this paper
• Instability, stabilization, and formulation of liquid protein pharmaceuticals.

  1999cited by this paper
• Stability of biocatalysts

  1999cited by this paper
• Stabilization against thermal inactivation promoted by sugars on enzyme structure and function: why is trehalose more effective than other sugars?

  1998cited by this paper
• Theoretical analysis of Lumry-Eyring models in differential scanning calorimetry.

  1992cited by this paper
• A simple model for proteins with interacting domains. Applications to scanning calorimetry data.

  1989cited by this paper
• Differential scanning calorimetry of the irreversible thermal denaturation of thermolysin.

  1988cited by this paper
• Biophysical Properties of Human Antibody Variable Domains

  year unknowncited by this paper

• Concentration‐dependent dimerization of staphylokinase variants with engineered surface charges

  2026cites this paper
• Application of a 2A-peptide system for polycistronic human IgG production in Leishmania tarentolae.

  2025cites this paper
• Superchaotropic Stabilization of Monomeric Protein States

  2025cites this paper
• Stability of Protein Pharmaceuticals: Recent Advances

  2024cites this paper
• Explanation of inconsistencies in the determination of human serum albumin thermal stability.

  2023cites this paper
• Correlation of In Vitro Kinetic Stability to Preclinical In Vivo Pharmacokinetics for a Panel of Anti-PD-1 Monoclonal Antibody Interleukin 21 Mutein Immunocytokines

  2023cites this paper
• Protein cohabitation: long-term immunoglobulin G storage at room temperature.

  2023cites this paper
• Specific anion effect on properties of HRV 3C protease.

  2022cites this paper
• Comparison of human blood serum DSC profiles in aqueous and PBS buffer solutions

  2021cites this paper
• Ultra-sensitive and label-free detection of the measles virus using an N-heterocyclic carbene-based electrochemical biosensor.

  2020cites this paper
• Changes in Serum Biomarkers of Oxidative Stress in Cattle Vaccinated with Tick Recombinant Antigens: A Pilot Study

  2020cites this paper
• Alternative Binding Scaffolds: Multipurpose Binders for Applications in Basic Research and Therapy

  2020cites this paper
• Using Differential Scanning Calorimetry (DSC) to Guide the Development of Non-Reduced Capillary Electrophoresis Sodium Dodecyl Sulfate (NR-CE-SDS) Methods for Monoclonal Antibodies.

  2020cites this paper
• Destabilization effect of imidazolium cation-Hofmeister anion salts on cytochrome c.

  2020cites this paper
• Relation of colloidal and conformational stabilities to aggregate formation in a monoclonal antibody.

  2019cites this paper
• A computational approach to get insights into multiple faces of additives in modulation of protein aggregation pathways.

  2019cites this paper